Optical coherence tomography predictors of progression of non-exudative age-related macular degeneration to advanced atrophic and exudative disease
Sign Up to like & getrecommendations! Published in 2021 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-021-05419-2
Abstract: To study the natural history of optical coherence tomography (OCT) imaging-based findings seen in non-exudative age-related macular degeneration (neAMD) and model their relative likelihood in predicting development of incomplete retinal pigment epithelium and outer retinal… read more here.
Keywords: optical coherence; age related; related macular; exudative age ... See more keywords
Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular Degeneration.
Sign Up to like & getrecommendations! Published in 2018 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2018.04.008
Abstract: PURPOSE The Medicare cost savings from the use of bevacizumab in the United States for the treatment of exudative age-related macular degeneration (AMD) were estimated by replacing the use of bevacizumab with ranibizumab and aflibercept.… read more here.
Keywords: savings use; use bevacizumab; exudative age; treatment ... See more keywords
Chinese medicine formula HB01 for treating exudative age-related macular degeneration: a 6 consecutive months of clinical observation study
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Traditional Chinese Medicine"
DOI: 10.1016/s0254-6272(18)30039-6
Abstract: Abstract Objective To evaluate the clinical efficacy of Chinese medicine formula HB01 on exudative age-related macular degeneration (AMD) patients who received HB01 for 6 months by analyzing relative indexes. Methods From July 2006 to August… read more here.
Keywords: medicine; formula hb01; exudative age; chinese medicine ... See more keywords
One-year outcomes of fixed treatment of intravitreal aflibercept for exudative age-related macular degeneration and the factor of visual prognosis
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000011737
Abstract: Abstract The aim of this study was to investigate the efficacy of periodic intravitreal aflibercept (IVA) in exudative age-related macular degeneration, and to explore the predictive factors for visual outcome. This is a prospective interventional… read more here.
Keywords: age related; related macular; age; exudative age ... See more keywords
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2020-316373
Abstract: Aims To identify the association between ranibizumab and risk of stroke and acute myocardial infarction (AMI) in patients with exudative age-related macular degeneration (AMD). Methods We identified patients aged ≥45 years who received ranibizumab for… read more here.
Keywords: risk; macular degeneration; age related; related macular ... See more keywords
Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot Study
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Retina and Vitreous"
DOI: 10.1186/s40942-021-00281-0
Abstract: Background and objective To evaluate the safety and efficacy of intravitreal sirolimus for persistent, exudative age-related macular degeneration (AMD). Methods This institutional review board approved, registered (NCT02357342), prospective, subject-masked, single center, randomized controlled trial in… read more here.
Keywords: macular degeneration; age related; related macular; exudative age ... See more keywords